Inventor

Branislav Musicki

Inventor

Nice, FR

Overview

2002–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 23 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%

C07DHeterocyclic compounds28%

A61KPreparations for medical, dental or toiletry purposes22%

C07HSugars8%

C07CAcyclic or carbocyclic compounds5%

Y02PClimate change mitigation technologies in the production or processing of goods3%

C07BGeneral methods of organic chemistry2%

PatentTitleYear

10,752,617Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))2020 10,647,706Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologies2020 10,618,890Benzimidazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))2020 10,550,110Tetrahydroquinoline sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (t))2020 10,457,637Benzenesulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (RORg(T))2019 10,287,278Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologies2019 10,246,440Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR g (T))2019 9,650,337'Method of synthesising 4-piperidin-4-yl-benzene-1,3-diol and the salts of same and novel compound tert-butyl 4-(2,4-dihydroxy-phenyl)-4-hydroxy-piperidine-1-carboxylate'2017 9,580,412'Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases'2017 9,526,732'Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies'2016 9,415,039'Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases'2016 9,388,149'Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases'2016 9,120,772'Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases'2015 9,090,596'Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies'2015 8,148,540'Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents'2012 7,439,253'Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors'2008 7,365,071'Heterocyclic compounds, preparation process and intermediates, and use as medicaments, in particular as Î²-lactamase inhibitors and antibacterials'2008 7,288,549'Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agents'2007 6,812,331'Aromatic derivatives substituted by a ribose, their preparation process and their use as medicaments'2004 6,583,119'Aromatic amides, preparation method and application as medicines'2003 6,579,902'Ribose-substituted aromatic amides, method for the production and use thereof as medicaments'2003 6,420,538'Aromatic amides, preparation method and application as medicines'2002 6,350,733'Aromatic derivatives substituted by a ribose, their method of preparation and application as medicine'2002

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2002–2007Patents assigned to AVENTIS PHARMA SA (6)· patent assignee history

2002–2012Based in Paris, FR· patent location history

2008–2012Patents assigned to MUSICKI BRANISLAV (2)· patent assignee history

2012Patents assigned to ASTRAZENECA (1)· patent assignee history

2012Patents assigned to ASZODI JOSEPH (1)· patent assignee history

2015–2020Patents assigned to GALDERMA RES & DEV (14)· patent assignee history

2015–2020Based in Nice, FR· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
GALDERMA RES & DEV	14	2015–2020
AVENTIS PHARMA SA	6	2002–2007
MUSICKI BRANISLAVself	2	2008–2012
ASTRAZENECA	1	2012
ASZODI JOSEPH	1	2012

Locations

Location	Patents	Span
Nice, FR	14	2015–2020
Paris, FR	9	2002–2012